On Oct 18, Acelrx Pharmaceuticals Received Written Notice From Nasdaq Notifying Co That It Is Not In Compliance With Minimum Bid Price Requirement; Will Evaluate Available Options To Regain Compliance With Minimum Bid Price Requirement
10月18日,Acelrx Pharmicals收到了納斯達克的書面通知,通知公司它不符合最低出價要求;將評估可用期權以重新遵守最低出價要求